Notifiable disease guidelines

Overview

The notifiable disease management guidelines are developed by the Alberta government with input and advice from medical officers of health, public health nurses, public health inspectors, laboratories, and medical infectious disease specialists.

The guidelines are provided to support practitioners in meeting the communicable disease management requirements in the Public Health Act.

Notifiable disease surveillance reports

• Lyme disease (tick surveillance summary reports)
• Notifiable disease annual summary reports
• Seasonal influenza summary reports
• Sexually transmitted infections and HIV 2018 report

Notifiable disease manual

• Notifiable Disease Report (NDR) Manual, 9th Edition
• Notifiable disease reporting references: MOH and Designate, Laboratories
• Notifiable disease acronyms and definitions

Disease management guidelines

Access all the notifiable disease guidelines on Open Alberta.

• Acute Flaccid Paralysis
• Aeromonas
• Amoebiasis
• Anthrax
• Bacillus Cereus
• Botulism
• Brucellosis
• California Serogroup Infection Including:
  • Jamestown Canyon Virus
  • Snow Shoe Hare Virus
• Campylobacteriosis
• Carbapenemase Producing Organism
• Cerebrospinal Fluid Isolates
• Chancroid
• Chikungunya Virus
• Chlamydia (includes perinatally acquired)
• Cholera (O1 & O139)
• Clostridium difficile – Associated Infection
• Clostridium Perfringens
• Coronavirus, Novel Including:
  • SARS
  • MERS
• Creutzfeldt-Jakob Disease (CJD)
• Cryptosporidiosis
• Cyclosporiasis
• Cytomegalovirus, Congenital
• Dengue Fever
• Diphtheria
• Disease in Unusual Form
• Eastern Equine Encephalitis
• Ebola Haemorrhagic Fever
• Echinococcosis (Alveolar)
• Enterovirus D68
• Epidemics
• Escherichia coli (Verotoxigenic)
• Flavivirus (Other)
• Giardiasis
• Gonorrhea (includes perinatally acquired)
• Haemolytic Uremic Syndrome (HUS)
• Haemophilus Influenzae Invasive
• Hantavirus Pulmonary Syndrome
• Hepatitis A
• Hepatitis B
• Hepatitis C – Acute
• Hepatitis C – Chronic
• Hepatitis E
• Herpes Simplex, Neonatal
• Histoplasmosis
• Human Immunodeficiency Virus (HIV)
• Influenza – Seasonal
• Japanese Encephalitis
• Legionellosis
• Leprosy
• Listeriosis
• Lyme Disease
• Lymphogranuloma Venereum
• Malaria
• Measles
• Meningococcal Disease, Invasive (IMD)
• Muco-Purulent Cervicitis
• Mumps
• Non-Gonococcal Urethritis
• Norovirus
• Paratyphoid Fever
• Pertussis
• Plague
• Pneumococcal Disease, Invasive (IPD)
• Poliomyelitis
• Powassan Encephalitis
• Psittacosis
• Q-Fever
• Rabies
• Rare or Emerging Communicable Disease
• Respiratory Syncytial Virus
• Rickettsial Infections
• Rotavirus
• Rubella
• Rubella, Congenital Infection / Syndrome
• Salmonellosis
• Severe Acute Pulmonary Disease Associate with Electronic Cigarette Use
• Severe Respiratory Illness (SRI)
• Shellfish Poisoning
• Shigellosis
• Smallpox
• Louis Encephalitis
• Staphylococcal Intoxication
• Streptococcal Disease Group A Invasive
• Streptococcal Disease Group B Newborn
• Subacute Sclerosing Panencephalitis
• Syphilis
• Syphilis, Congenital
• Tetanus
• Toxoplasmosis, Congenital
• Trichinosis
• Tuberculosis
• Tularemia
• Typhoid Fever
• Varicella (Chickenpox)
• Vibrio Cholerae (non O1, non O139)
• Vibrio Parahaemolyticus
• Viral Haemorrhagic Fever Including:
  • Argentine Haemorrhagic Fever
  • Crimean Congo Haemorrhagic Fever
  • Lassa Fever
  • Marburg Haemorrhagic Fever
  • Rift Valley Haemorrhagic Fever
• West Nile virus
• Western Equine Encephalitis
• Yellow Fever
• Yersiniosis
• Zika virus

Forms and related documents

• Acute rheumatic fever medication payment coverage request form (DOCX, 115 KB)
• Carbapenem producing organism form (DOC, 37 KB)
• Carbapenem producing organism form definitions (PDF, 83 KB)
• Enteric transmission risk assessment and exclusion table
• Enterovirus D68 enhanced surveillance form (DOCX, 116 KB)
• Hantavirus – enhanced surveillance form  (DOCX, 117 KB)
• Hepatitis A – hypothesis generating questionnaire, PHAC (PDF, 807 KB)
• Hospitalized seasonal influenza report form (DOCX, 114 KB)
• Hospitalized seasonal influenza form definitions (PDF, 43 KB)
• Listeria questionnaire and instructions (PHAC) (PDF, 328 KB)
• Lyme disease – laboratory tests
• Lyme disease – notes for clinicians
• Outbreak reporting form (DOCX, 56 KB)
• Outbreak reporting form definitions (PDF, 205 KB)
• Outbreak reporting form tuberculosis definitions and instructions (PDF, 196 KB)
• Outbreak response protocol for unusual outbreaks
• Perinatally acquired notifiable disease enhanced report form (DOCX, 99 KB)
• Post exposure prophylaxis form – Hib, IMD, Pertussis (DOCX, 64 KB)
• Post-exposure management and prophylaxis guidelines – HIV, HBV, HCV and STIs
• Prenatal HIV: public health guidelines
• Prenatal screening guidelines
• Prenatal syphilis rescreening form (PDF, 1.6 MB)
• Rabies prevention and control manual (PDF, 1 MB)
• Sexually transmitted infections notification form (PDF, 142 MB)
• Sexually transmitted infections treatment guidelines
• Tick surveillance definitions (PDF 177 KB)
• Tuberculosis prevention and control guidelines for Alberta
• West Nile virus – notes for clinicians

Contact

Email: health.cd@gov.ab.ca